期刊文献+

阿仑膦酸钠对破骨细胞分化中c-fos基因表达的影响

Effect of Alendronate Sodium on c-fos Gene in Osteoclast Differentiation
下载PDF
导出
摘要 目的探讨阿仑膦酸钠对破骨细胞分化中c-fos基因的作用机制。方法将不同浓度的阿仑膦酸钠作用于小鼠破骨细胞,采用Western blot检测小鼠破骨细胞分化中c-fos基因的表达情况。结果阿仑膦酸钠组TRAP阳性破骨细胞数目和c-fos基因的表达显著低于空白对照组;且加入10-4mol/L、10-6mol/L、10-8mol/L浓度阿仑膦酸钠后,c-fos表达受抑制程度依次增强;而在10-8mol/L、10-10mol/L、10-12mol/L浓度中,c-fos表达受抑制程度依次减弱。结论阿仑膦酸钠可使破骨细胞分化中的c-fos基因受到抑制,其抑制程度与阿仑膦酸钠的浓度有关,10-8mol/L浓度时抑制作用最强。 Objective To study the probably mechanism of alendronate sodium to c - fos gene in osteoclast differentiation. Methods Different concentrations of alendronate sodium had effect on mice osteoclast, c - fos expression in mouse osteoelast differentiation was detedcted using Western blot. Results The number of TRAP* osteoclasts and the expression of c - los gene from alendronate group were significantly lower than those in control group ( P 〈 0.05) , and the expression of c - los was enhanced with the concentration increase of alendronate in 10^-4 mol/L, 10^-6 mol/L, 10^-8 mol/L, but the expression of c -los was decreased with the concentration increase of alendronate in 10^-8 mol/L, 10^-10mol/L, 10^-12mol/L. Conclusion Alendronate sodium can make osteoelast differentiation of c -los gene robe restrained. Its inhibition degree was associated with alendronate sodium concentration. The strongest inhibition effect on c - los expression was at concentration of 10^-8 mol/L.
出处 《医学研究杂志》 2011年第7期71-74,共4页 Journal of Medical Research
基金 河北省科学技术研究与发展计划项目(08276101D-73)
关键词 阿仑膦酸钠 c—fos 破骨细胞 Western BLOT Alendronate sodium c - fos Osteoelast Western blot
  • 相关文献

参考文献16

  • 1Matsuo K, Ray N. Osteoclasts, mononuclear phagocytes, and e - Fos : new insight into usteoimmunology. Keio J Med, 2004,53 (2) : 78 -84.
  • 2Tulchinsky E. Fos family members:regulation, structure and role in oncogenic transformation. Histol Histopathol, 2000,15 ( 3 ) : 921 - 928.
  • 3Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/ RANK/RANKL:involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev,2004,15 (6) :457 - 475.
  • 4Macara IG. Oncogenes and cellular signal transduction. Physiol Rev, 1989,69(3) :797.
  • 5Takayanaqi H, Kim S, Koqa T, et al. Induction and activation of thetranscription factor NFATcl (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclast. Dev Cell, 2002,3 ( 6 ) : 889 - 901.
  • 6Kimmel DB. Mechanism of action, pharmacokinetic and pharmacody- namic profile, and clinical applications of nitrogen - containing bi- sphosphonates. J Dent Res,2007,86(11) :1022 - 1033.
  • 7Srisubut S, Teerakapong A, Vatraphodes T, et al. Effect of local de- livery of a lendronate on bone formation in bionctive glass grafting in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007,104 (4) :e11 -e16.
  • 8Jensen TB, Bechtold JE, Chen X, et al. Systemic alendronate treat- ment in proves fixation of press - fit implants: a canine study using nonloaded implants. J Orthop Res,2007,25 (6) : 772 - 778.
  • 9严鹏霄,崔维顶,胡继坤.阿仑磷酸钠、辛伐他汀对体外成骨细胞和破骨细胞的作用[J].南京医科大学学报(自然科学版),2009,29(12):1690-1693. 被引量:6
  • 10Romane]lo M, Bivi N, Pines A,et aL Bispbosphonates activate nucleo- tide receptors signaling and induce the expression of Hsp90 in osteo- blast- like cell lines. Bone ,2006,39(4 ) :739 -753.

二级参考文献24

  • 1余利鹏,范卫民,张宁,罗永湘.阿托伐他汀对骨髓来源的成骨细胞中OPG mRNA/RANKL mRNA水平的影响[J].南京医科大学学报(自然科学版),2005,25(8):544-546. 被引量:2
  • 2Purdue PE,Koulouvaris P,Nestor BJ,et al. The central role of wear debris in periprosthetic osteolysis[J]. HSS J, 2006,2(2) : 102-113.
  • 3Wimhurst JA,Brooks RA,Rushton N. Inflammatory responses of human primary macrophages to particulate bone cements in vitro[J]. J Bone Joint Surg Br,2001,83 (2) :278-282.
  • 4Kwan Tat S,Padrines M,Theoleyre S,et al. IL-6,RANKL, TNF-al-Pha/IL1:interrelations in bone resorption patho- physiology[J]. Cytokine Growth Factor Rev, 2004,15 ( 1 ) : 49-60.
  • 5Granchi D,Ciapetti G,Amato I,et al. The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation [J].Biomaterials, 2004,25 (18) : 4037-4045.
  • 6Rakshit DS,Ly K,Sengupta TK,et al. Wear debris inhibition of anti-osteoclastogenic signaling by IL6 and IFN-gamma:mechanistic insights and implications for periprosthetic osteolysis[J]. J Bone Joint Surg Am, 2006,88 (4) :788-799.
  • 7Soininvaara TA, Jurvelin JS, Miettinen H J, et al. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty : a one-year, randomized, controlled trial of 19 patients[J]. Calcif Tissue Int, 2002,71 (6) :472-477.
  • 8Arabmotlagh M,Rittmeister M,Hennigs T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study[J]. J Orthop Res,2006,24(7) : 1336-1341.
  • 9Petit A,Mwale F,Antoniou J,et al. Effect of bisphosphonates on the stimulation of macrophages by alumina ceramic particles:a comparison with ultra-high-molecularweight polyethylene [J]. J Mater Sci Mater Med,2006,17(7):667-673.
  • 10Hughes D,Wright K,Uy H,et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo [J]. J Bone Miner Res, 1995, t0(10) : 1478-1487.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部